Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica C Hassel

Showing results (91-100 of 272) with videos related to

Pageof 28
Sort By:
Cancers|October 14, 2022
Long-Term Management of Advanced Basal Cell Carcinoma: Current Challenges and Future PerspectivesMarkus V Heppt, Christoffer Gebhardt, Jessica C Hassel, et al.
Melanoma Research|February 28, 2018
STAT5 expression correlates with recurrence and survival in melanoma patients treated with interferon-αDevayani Machiraju, Iris Moll, Christoffer Gebhardt, et al.
Experimental Dermatology|January 18, 2014
Lecithin retinol acyltransferase as a potential prognostic marker for malignant melanomaJessica C Hassel, Philipp M Amann, Dirk Schadendorf, et al.
Cancers|December 23, 2022
Postoperative Radiotherapy and the Role of Regional Lymph Node Irradiation in Localized Merkel Cell Carcinoma: A Single-Center Retrospective AnalysisLisa-Antonia Dinges, Tanja Eichkorn, Sebastian Regnery, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 11, 2017
Absolute number of new lesions on <sup>18</sup>F-FDG PET/CT is more predictive of clinical response than SUV changes in metastatic melanoma patients receiving ipilimumabHoda Anwar, Christos Sachpekidis, Julia Winkler, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 18, 2020
Interim [<sup>18</sup>F]FDG PET/CT can predict response to anti-PD-1 treatment in metastatic melanomaChristos Sachpekidis, Annette Kopp-Schneider, Leyun Pan, et al.
Cancers|October 23, 2021
Fractal and Multifractal Analysis of PET-CT Images for Therapy Assessment of Metastatic Melanoma Patients under PD-1 Inhibitors: A Feasibility StudyAnastasia Kosmou, Christos Sachpekidis, Leyun Pan, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 14, 2017
Safe Administration of An Anti-PD-1 Antibody to Kidney-transplant Patients: 2 Clinical Cases and Review of the LiteratureJulia K Winkler, Ralf Gutzmer, Carolin Bender, et al.
Head & Neck|November 13, 2015
Raster-scanned intensity-controlled carbon ion therapy for mucosal melanoma of the paranasal sinusAngela Mohr, Naved Chaudhri, Jessica C Hassel, et al.
Oncotarget|May 7, 2016
Which melanoma patient carries a BRAF-mutation? A comparison of predictive modelsThomas Eigentler, Zeinab Assi, Jessica C Hassel, et al.
Pageof 28

Showing results (91-100 of 272) with videos related to

Sort By:
Pageof 28
Cancers|October 14, 2022
Long-Term Management of Advanced Basal Cell Carcinoma: Current Challenges and Future PerspectivesMarkus V Heppt, Christoffer Gebhardt, Jessica C Hassel, et al.
Melanoma Research|February 28, 2018
STAT5 expression correlates with recurrence and survival in melanoma patients treated with interferon-αDevayani Machiraju, Iris Moll, Christoffer Gebhardt, et al.
Experimental Dermatology|January 18, 2014
Lecithin retinol acyltransferase as a potential prognostic marker for malignant melanomaJessica C Hassel, Philipp M Amann, Dirk Schadendorf, et al.
Cancers|December 23, 2022
Postoperative Radiotherapy and the Role of Regional Lymph Node Irradiation in Localized Merkel Cell Carcinoma: A Single-Center Retrospective AnalysisLisa-Antonia Dinges, Tanja Eichkorn, Sebastian Regnery, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 11, 2017
Absolute number of new lesions on <sup>18</sup>F-FDG PET/CT is more predictive of clinical response than SUV changes in metastatic melanoma patients receiving ipilimumabHoda Anwar, Christos Sachpekidis, Julia Winkler, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 18, 2020
Interim [<sup>18</sup>F]FDG PET/CT can predict response to anti-PD-1 treatment in metastatic melanomaChristos Sachpekidis, Annette Kopp-Schneider, Leyun Pan, et al.
Cancers|October 23, 2021
Fractal and Multifractal Analysis of PET-CT Images for Therapy Assessment of Metastatic Melanoma Patients under PD-1 Inhibitors: A Feasibility StudyAnastasia Kosmou, Christos Sachpekidis, Leyun Pan, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 14, 2017
Safe Administration of An Anti-PD-1 Antibody to Kidney-transplant Patients: 2 Clinical Cases and Review of the LiteratureJulia K Winkler, Ralf Gutzmer, Carolin Bender, et al.
Head & Neck|November 13, 2015
Raster-scanned intensity-controlled carbon ion therapy for mucosal melanoma of the paranasal sinusAngela Mohr, Naved Chaudhri, Jessica C Hassel, et al.
Oncotarget|May 7, 2016
Which melanoma patient carries a BRAF-mutation? A comparison of predictive modelsThomas Eigentler, Zeinab Assi, Jessica C Hassel, et al.
Pageof 28